Abbott Pharmaceuticals recently pulled Meridia (Sibutramine) from the market. For years, they refused to run efficacy trials to confirm its use for the treatment of fibromyalgia, post-traumatic stress disorder, reflex sympathetic dystrophy, and myriad other diseases. Below is a series of documents demonstrating this.
| PRIMARY PERIPHERAL vs. SECONDARY CNS REFERRED PAIN |
 |
| ATTEMPT BY ABBOTT TO PATENT MERIDIA FOR TREATMENT OF FIBROMYALGIA |
 |
| ABBOTT PATENT (2) |
 |
| ABBOTT PATENT (3) |
 |
| ABBOTT PATENT (4) |
 |
|
| NEW ENGLAND JOURNAL OF MEDICINE ON TREATMENT OF FIBROMYAGLIA WITH SIBUTRAMINE |
 |
| (2) |
 |
|
| RAPID TREATMENT OF ALL OF THE VARIED SYMPTOMS OF FIBROMYALGIA WITH SIBUTRAMINE MONOHYDRATE |
 |
| (2) |
 |
|
Though pills curbed my appetite, my heart raced and it was difficult to sleep and remember things.
ReplyDeletemore info
I had a good experience with it. I used it for 30 days and lost 23 pounds I went from 281 lbs to 258 lbs. Very good product.
ReplyDeleteMeridia